Two icodextrin exchanges for better fluid and blood pressure control
Part of Kidney & urinary clinical trials.
This trial compares using two doses of icodextrin (a dialysis solution) instead of one to see if it improves fluid balance and blood pressure in children on peritoneal dialysis. It may help those with high blood pressure and low urine output.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 18 years old.
- You have been on peritoneal dialysis (CAPD or CCPD) for at least 4 weeks.
- Your average blood pressure over 24 hours is high for your age, sex, and height.
- You make less than 200 mL of urine per day.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a modified version of daily peritoneal dialysis (M-CAPD) versus the standard version (C-CAPD) for children in low-resource settings who have end-stage kidney disease. It aims to see if the modified schedule works better for clearing waste and fluid.
This trial studies how much of a dialysis fluid called icodextrin stays in your body after one or two doses. It is for people on long-term peritoneal dialysis who are stable and can follow a specific daily schedule.
This study tests whether a special dialysis fluid called icodextrin can help people on a low-dose form of peritoneal dialysis stay on that low dose longer before needing a full dose. It is for adults who still make some urine and can do dialysis at home.
This trial studies a type of peritoneal dialysis using a special fluid called icodextrin once a day. It may help people who still make a good amount of urine to remove extra fluid more easily.
This study tests how well a continuous glucose monitor (CGM) works in people with diabetes who are also using a special dialysis fluid called icodextrin. The goal is to see if the CGM gives accurate readings while on this treatment.
This Phase 3 trial studies how well a new peritoneal dialysis solution works and whether it is safe. It’s meant for adults with kidney failure who already do a specific type of at-home dialysis.
Hear when a new Children on Chronic Peritoneal Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.